Kaiser Permanente Ventures has added two new limited partners, bringing its current fund to $170 million, the firm announced. It has also expanded its team, adding Sam Brasch as a director and Yan Pu as an analyst. Brasch was most recently at Frazier Healthcare Ventures. Pu worked previously in life sciences and healthcare strategy consulting with IMS Health and Navigant Consulting. Kaiser Permanente Ventures invests in medical device, health care service, diagnostic and drug delivery.
Kaiser Permanente Ventures (KPV) has added two external health plans as limited partners to its venture fund, bringing its current fund to $170M. Founded in 1999, KPV invests in medical device, health care service, diagnostic, drug delivery, and HCIT companies that support Kaiser Permanente’s focus on health care quality and affordability.
KPV also welcomes Sam Brasch and Yan Pu to the investment team. Sam has joined as a Director to lead investments in the medical device and healthcare services sectors. Sam was most recently at Frazier Healthcare Ventures where he focused on venture and growth equity investments. Prior to Frazier, Sam worked in global management roles at Medtronic, Inc and with several venture-backed healthcare companies.
Yan has joined as an analyst after three years in life sciences and healthcare strategy consulting with IMS Health and Navigant Consulting. Yan’s clients included pharmaceutical and biotechnology companies, health plans and hospitals. Additionally, Yan spent one year leading a Stanford Asian Liver Center international healthcare program in rural China.